Cleveland BioLabs
CBLI
#9801
Rank
ยฃ36.83 M
Marketcap
ยฃ2.38
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Market capitalization of Cleveland BioLabs (CBLI)

Last known market cap: ยฃ36.83 Million

As of December 2025 Cleveland BioLabs has a market cap of ยฃ36.83 Million. This makes Cleveland BioLabs the world's 9801th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cleveland BioLabs from 2006 to 2022

End of year Market Cap

Year Marketcap Change
2022ยฃ40.55 M11.58%
2021ยฃ36.35 M10.34%
2020ยฃ32.94 M535.17%
2019ยฃ5.18 M-42.3%
2018ยฃ8.98 M-73.14%
2017ยฃ33.46 M164.68%
2016ยฃ12.64 M-51.13%
2015ยฃ25.87 M147.28%
2014ยฃ10.46 M-67.35%
2013ยฃ32.04 M-12.93%
2012ยฃ36.8 M-43.67%
2011ยฃ65.34 M-51.76%
2010ยฃ0.13 B227.74%
2009ยฃ41.32 M107.62%
2008ยฃ19.9 M-65.17%
2007ยฃ57.13 M87.77%
2006ยฃ30.43 M

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Onconova Therapeutics
ONTX
ยฃ15.69 M-57.40%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
ยฃ0.79 B 2,067.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ133.34 B 361,926.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ190.35 B 516,707.23%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
ยฃ79.69 B 216,261.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ90.75 B 246,289.98%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
ยฃ73.35 B 199,048.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
ยฃ12.18 M-66.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ679.86 B 1,845,699.95%๐Ÿ‡บ๐Ÿ‡ธ USA